HPV Vaccine Gap: UK Students at Cancer Risk

A significant number of UK students, approximately one in four, are not receiving the HPV vaccine before leaving high school. This gap in vaccination coverage puts them at a higher risk for several types of cancer, including cervical, mouth, and throat cancers. The latest data from the UK Health Security Agency indicates that HPV vaccine uptake for Year 10 students in England stands at 75.5% for girls and 70.5% for boys, a notable decrease from pre-pandemic rates which approached 90%.

Regional disparities in vaccine uptake are evident, with London reporting the lowest rates and East England the highest. While Year 9 uptake has seen a slight increase compared to the previous academic year, overall coverage remains a concern. The HPV vaccine is highly effective, preventing up to 90% of cervical cancers and protecting against other HPV-related cancers in both boys and girls. It is recommended to be administered as a single jab in school from Year 8.

To address this issue, the government plans to expand catch-up vaccination access in 2026 through initiatives like the National Cancer Plan, potentially including community pharmacies. This is part of a broader NHS strategy aiming to eliminate cervical cancer by 2040. Health officials urge parents to ensure their children receive the vaccine, either through school programs or by contacting their GP if they missed it. It's also emphasized that even vaccinated individuals should attend cervical screening appointments.